$AVAH
Aveanna Healthcare Holdings, Inc.

2023 Q4 Form 10-Q Financial Statement

#000095017023061484 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4
Revenue $478.8M
YoY Change 8.09%
Cost Of Revenue $330.4M
YoY Change 7.12%
Gross Profit $148.4M
YoY Change 10.3%
Gross Profit Margin 31.0%
Selling, General & Admin $115.3M
YoY Change 28.78%
% of Gross Profit 77.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.284M
YoY Change -33.21%
% of Gross Profit 2.21%
Operating Expenses $119.2M
YoY Change 33.07%
Operating Profit $29.29M
YoY Change 511.93%
Interest Expense -$60.87M
YoY Change -313.86%
% of Operating Profit -207.79%
Other Income/Expense, Net -$20.00K
YoY Change -100.04%
Pretax Income -$31.60M
YoY Change -246.08%
Income Tax -$5.859M
% Of Pretax Income
Net Earnings -$25.74M
YoY Change -205.92%
Net Earnings / Revenue -5.37%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.13
COMMON SHARES
Basic Shares Outstanding 190.7M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $43.94M
YoY Change -31.0%
Cash & Equivalents $43.94M
Short-Term Investments
Other Short-Term Assets $9.452M
YoY Change -3.2%
Inventory
Prepaid Expenses $15.68M
Receivables $236.6M
Other Receivables $0.00
Total Short-Term Assets $314.9M
YoY Change 0.9%
LONG-TERM ASSETS
Property, Plant & Equipment $20.55M
YoY Change -17.54%
Goodwill $1.055B
YoY Change -22.93%
Intangibles $94.01M
YoY Change -3.85%
Long-Term Investments
YoY Change
Other Assets $58.18M
YoY Change -37.1%
Total Long-Term Assets $1.298B
YoY Change -21.86%
TOTAL ASSETS
Total Short-Term Assets $314.9M
Total Long-Term Assets $1.298B
Total Assets $1.613B
YoY Change -18.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $30.13M
YoY Change -38.46%
Accrued Expenses $93.31M
YoY Change 49.32%
Deferred Revenue
YoY Change
Short-Term Debt $3.955M
YoY Change
Long-Term Debt Due $9.200M
YoY Change 0.0%
Total Short-Term Liabilities $354.8M
YoY Change 0.87%
LONG-TERM LIABILITIES
Long-Term Debt $1.276B
YoY Change -0.49%
Other Long-Term Liabilities $3.039M
YoY Change 393.34%
Total Long-Term Liabilities $1.279B
YoY Change -0.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $354.8M
Total Long-Term Liabilities $1.279B
Total Liabilities $1.740B
YoY Change -0.16%
SHAREHOLDERS EQUITY
Retained Earnings -$1.371B
YoY Change 37.27%
Common Stock $1.242B
YoY Change 1.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$129.6M
YoY Change
Total Liabilities & Shareholders Equity $1.613B
YoY Change -18.26%

Cashflow Statement

Concept 2023 Q4
OPERATING ACTIVITIES
Net Income -$25.74M
YoY Change -205.92%
Depreciation, Depletion And Amortization $3.284M
YoY Change -33.21%
Cash From Operating Activities -$3.005M
YoY Change -114.18%
INVESTING ACTIVITIES
Capital Expenditures $1.568M
YoY Change -155.7%
Acquisitions
YoY Change
Other Investing Activities $2.000K
YoY Change -100.24%
Cash From Investing Activities -$1.568M
YoY Change -56.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 221.0K
YoY Change -99.23%
NET CHANGE
Cash From Operating Activities -3.005M
Cash From Investing Activities -1.568M
Cash From Financing Activities 221.0K
Net Change In Cash -4.352M
YoY Change -109.42%
FREE CASH FLOW
Cash From Operating Activities -$3.005M
Capital Expenditures $1.568M
Free Cash Flow -$4.573M
YoY Change -119.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
dei Entity Central Index Key
EntityCentralIndexKey
0001832332
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40362
dei Entity Registrant Name
EntityRegistrantName
Aveanna Healthcare Holdings Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-4717209
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Interstate North Parkway SE
dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30339
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
441-1580
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
AVAH
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
190733153
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48294000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19217000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
235668000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
221237000
CY2023Q3 avah Receivables Under Insured Programs Current
ReceivablesUnderInsuredProgramsCurrent
10724000
CY2022Q4 avah Receivables Under Insured Programs Current
ReceivablesUnderInsuredProgramsCurrent
4395000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12352000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15089000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
11207000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
9813000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
318245000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
269751000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22000000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22752000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
51789000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
54601000
CY2023Q3 us-gaap Goodwill
Goodwill
1054552000
CY2022Q4 us-gaap Goodwill
Goodwill
1159688000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
95188000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
95863000
CY2023Q3 avah Receivables Under Insured Programs Noncurrent
ReceivablesUnderInsuredProgramsNoncurrent
23186000
CY2022Q4 avah Receivables Under Insured Programs Noncurrent
ReceivablesUnderInsuredProgramsNoncurrent
22865000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
89743000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
86240000
CY2023Q3 us-gaap Assets
Assets
1654703000
CY2022Q4 us-gaap Assets
Assets
1711760000
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
36527000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
44624000
CY2023Q3 avah Accrued Payroll And Employee Benefits
AccruedPayrollAndEmployeeBenefits
75588000
CY2022Q4 avah Accrued Payroll And Employee Benefits
AccruedPayrollAndEmployeeBenefits
43836000
CY2023Q3 avah Current Portion Of Insurance Reserves Insured Programs
CurrentPortionOfInsuranceReservesInsuredPrograms
10724000
CY2022Q4 avah Current Portion Of Insurance Reserves Insured Programs
CurrentPortionOfInsuranceReservesInsuredPrograms
4395000
CY2023Q3 avah Current Portion Of Insurance Reserves
CurrentPortionOfInsuranceReserves
18939000
CY2022Q4 avah Current Portion Of Insurance Reserves
CurrentPortionOfInsuranceReserves
27531000
CY2023Q3 avah Securitization Obligations
SecuritizationObligations
155000000
CY2022Q4 avah Securitization Obligations
SecuritizationObligations
140000000
CY2023Q3 us-gaap Loans Payable Current
LoansPayableCurrent
9200000
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
9200000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13972000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13070000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
44350000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
43841000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
364300000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
326497000
CY2023Q3 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
1277582000
CY2022Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
1281082000
CY2023Q3 avah Long Term Insurance Reserves Insured Programs
LongTermInsuranceReservesInsuredPrograms
23186000
CY2022Q4 avah Long Term Insurance Reserves Insured Programs
LongTermInsuranceReservesInsuredPrograms
22865000
CY2023Q3 avah Long Term Insurance Reserves
LongTermInsuranceReserves
44291000
CY2022Q4 avah Long Term Insurance Reserves
LongTermInsuranceReserves
35470000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
42603000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
45818000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4419000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3844000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1900000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
359000
CY2023Q3 us-gaap Liabilities
Liabilities
1758281000
CY2022Q4 us-gaap Liabilities
Liabilities
1715935000
CY2023Q3 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2135000
CY2022Q4 avah Deferred Restricted Stock Units
DeferredRestrictedStockUnits
2135000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
190733153
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
190733153
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188859165
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
188859165
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1907000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1888000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1237878000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1228512000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1345498000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1236710000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-105713000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6310000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1654703000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1711760000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
478010000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
443009000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1416368000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1336498000
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
330746000
CY2022Q4 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
308426000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
969384000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
912046000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
91004000
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89542000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
273967000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
267283000
CY2023Q3 avah Corporate Expenses
CorporateExpenses
27446000
CY2022Q4 avah Corporate Expenses
CorporateExpenses
33215000
avah Corporate Expenses
CorporateExpenses
84735000
avah Corporate Expenses
CorporateExpenses
105984000
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
470207000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2962000
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4917000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10494000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16774000
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
428000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
466000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
69000
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3360000
CY2022Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2122000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6593000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1953000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-76352000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
4787000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21221000
us-gaap Operating Income Loss
OperatingIncomeLoss
-437818000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
50000
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
164000
us-gaap Investment Income Interest
InvestmentIncomeInterest
238000
us-gaap Investment Income Interest
InvestmentIncomeInterest
369000
CY2023Q3 us-gaap Interest Expense
InterestExpense
39599000
CY2022Q4 us-gaap Interest Expense
InterestExpense
28462000
us-gaap Interest Expense
InterestExpense
113542000
us-gaap Interest Expense
InterestExpense
73745000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14143000
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
45140000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27124000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
86523000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101758000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21629000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-107401000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-424671000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
631000
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2669000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1387000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-416000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-102389000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
24298000
us-gaap Net Income Loss
NetIncomeLoss
-108788000
us-gaap Net Income Loss
NetIncomeLoss
-424255000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.29
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189139000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
186113000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189632000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
185327000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.29
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189139000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
186166000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189632000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185327000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-6737000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3413000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-102389000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-105713000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
200137000
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3512000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
24298000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
227947000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6310000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
945000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8440000
us-gaap Net Income Loss
NetIncomeLoss
-108788000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-105713000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
635816000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2278000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14108000
us-gaap Net Income Loss
NetIncomeLoss
-424255000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
227947000
us-gaap Profit Loss
ProfitLoss
-108788000
us-gaap Profit Loss
ProfitLoss
-424255000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10494000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16774000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3983000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5221000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12490000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12722000
us-gaap Share Based Compensation
ShareBasedCompensation
10143000
us-gaap Share Based Compensation
ShareBasedCompensation
14108000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
470207000
avah Gain Loss On Disposition Or Impairment Of Licenses Property And Equipment And Internal Use Software
GainLossOnDispositionOrImpairmentOfLicensesPropertyAndEquipmentAndInternalUseSoftware
-2086000
avah Gain Loss On Disposition Or Impairment Of Licenses Property And Equipment And Internal Use Software
GainLossOnDispositionOrImpairmentOfLicensesPropertyAndEquipmentAndInternalUseSoftware
-1815000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2584000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
89634000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
575000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-293000
avah Non Cash Gain On Acquisition
NonCashGainOnAcquisition
5090000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14431000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
921000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-5247000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-6825000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12657000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1878000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7861000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2395000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
31752000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-4569000
us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
229000
us-gaap Increase Decrease In Self Insurance Reserve
IncreaseDecreaseInSelfInsuranceReserve
5884000
avah Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-11991000
avah Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-15845000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-6944000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1932000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25677000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8166000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2027000
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
460000
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
11725000
avah Purchase Of Certificates Of Need
PurchaseOfCertificatesOfNeed
2678000
avah Payments To Acquire Property Plant And Equipment And Internal Use Software
PaymentsToAcquirePropertyPlantAndEquipmentAndInternalUseSoftware
4548000
avah Payments To Acquire Property Plant And Equipment And Internal Use Software
PaymentsToAcquirePropertyPlantAndEquipmentAndInternalUseSoftware
8800000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7226000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22092000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
945000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2278000
us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
45000000
us-gaap Proceeds From Accounts Receivable Securitization
ProceedsFromAccountsReceivableSecuritization
40000000
us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
30000000
us-gaap Repayments Of Accounts Receivable Securitization
RepaymentsOfAccountsReceivableSecuritization
20000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
20000000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
15000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
20000000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
15000000
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
59700000
avah Repayment Of Term Loans
RepaymentOfTermLoans
6900000
avah Repayment Of Term Loans
RepaymentOfTermLoans
6600000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7293000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7564000
avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
521000
avah Payments Of Financing Lease Obligations
PaymentsOfFinancingLeaseObligations
581000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1047000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
218000
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
-10442000
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
3566000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10626000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
63449000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29077000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
33191000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19217000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30490000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48294000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
63681000
us-gaap Interest Paid Net
InterestPaidNet
99291000
us-gaap Interest Paid Net
InterestPaidNet
69572000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
766000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1410000
us-gaap Nature Of Operations
NatureOfOperations
<p id="notes_to_unaudited_consolidated_financia" style="text-indent:-4.749%;padding-left:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1. DESCRIPTION</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> OF BUSINESS</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Aveanna Healthcare Holdings Inc. (together with its consolidated subsidiaries, referred to herein as the “Company”) is headquartered in Atlanta, Georgia and has locations in </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">33</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> states with concentrations in California, Texas and Pennsylvania, providing a broad range of pediatric and adult healthcare services including nursing, hospice, rehabilitation services, occupational nursing in schools, therapy services, day treatment centers for medically fragile and chronically ill children and adults, as well as delivery of enteral nutrition and other products to patients. The Company also provides case management services in order to assist families and patients by coordinating the provision of services between insurers or other payers, physicians, hospitals, and other healthcare providers. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization.</span></p>
CY2023Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
33
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#231f20;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="margin-left:4.533%;text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#231f20;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company’s accounting and reporting policies conform with U.S. GAAP. In preparing the interim unaudited consolidated financial statements, the Company is required to make estimates and assumptions that impact the amounts reported in these interim unaudited consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.</span></p>
CY2023Q3 avah Estimated Price Concession
EstimatedPriceConcession
57200000
CY2022Q4 avah Estimated Price Concession
EstimatedPriceConcession
52600000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2022Q4 avah Swingline Loan
SwinglineLoan
0
CY2023Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1079300000
CY2023Q3 us-gaap Derivative Assets
DerivativeAssets
84334000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
81750000
CY2022Q4 us-gaap Goodwill
Goodwill
1159688000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
CY2023Q3 us-gaap Goodwill
Goodwill
1054552000
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1317050000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1323950000
CY2023Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
30268000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
33668000
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
1286782000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1290282000
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
9200000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9200000
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1277582000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1281082000
CY2023Q1 avah Letter Of Credit Sublimit
LetterOfCreditSublimit
40000000
CY2023Q1 avah Letter Of Credit Sublimit
LetterOfCreditSublimit
30000000
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1100000
us-gaap Interest Expense Debt
InterestExpenseDebt
3600000
CY2022Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1600000
us-gaap Interest Expense Debt
InterestExpenseDebt
4900000
CY2023Q3 avah Swingline Loan
SwinglineLoan
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1400000
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.006
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.013
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.123
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
avah Recognized Tax Benefits
RecognizedTaxBenefits
1500000
CY2023 us-gaap Malpractice Insurance Deductible1
MalpracticeInsuranceDeductible1
1500000
CY2023 us-gaap Malpractice Insurance Maximum Coverage Per Incident
MalpracticeInsuranceMaximumCoveragePerIncident
5000000
CY2023Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
97100000
CY2022Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
90300000
CY2018Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
75000000
CY2019Q4 avah Break Up Fee Payable
BreakUpFeePayable
0
us-gaap Loss Contingency Name Of Defendant
LossContingencyNameOfDefendant
Epic/Freedom, LLC (“Seller”), Webster Capital Corporation, and Webster Equity Partners (collectively, the “Defendants”)
CY2020Q3 us-gaap Escrow Deposit
EscrowDeposit
7100000
CY2023Q2 us-gaap Escrow Deposit
EscrowDeposit
6800000
CY2023Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
7900000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
478010000
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
330746000
CY2023Q3 us-gaap Gross Profit
GrossProfit
147264000
CY2023Q3 avah Gross Margin Percentage
GrossMarginPercentage
0.308
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
443009000
CY2022Q4 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
308426000
CY2022Q4 us-gaap Gross Profit
GrossProfit
134583000
CY2022Q4 avah Gross Margin Percentage
GrossMarginPercentage
0.304
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1416368000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
969384000
us-gaap Gross Profit
GrossProfit
446984000
avah Gross Margin Percentage
GrossMarginPercentage
0.316
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1336498000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
912046000
us-gaap Gross Profit
GrossProfit
424452000
avah Gross Margin Percentage
GrossMarginPercentage
0.318
CY2023Q3 us-gaap Gross Profit
GrossProfit
147264000
CY2022Q4 us-gaap Gross Profit
GrossProfit
134583000
us-gaap Gross Profit
GrossProfit
446984000
us-gaap Gross Profit
GrossProfit
424452000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
91004000
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89542000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
273967000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
267283000
CY2023Q3 avah Corporate Expenses
CorporateExpenses
27446000
CY2022Q4 avah Corporate Expenses
CorporateExpenses
33215000
avah Corporate Expenses
CorporateExpenses
84735000
avah Corporate Expenses
CorporateExpenses
105984000
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
105136000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
470207000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2962000
CY2022Q4 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4917000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
10494000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16774000
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
428000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
466000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
69000
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3360000
CY2022Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2122000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
6593000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1953000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-76352000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
4787000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21221000
us-gaap Operating Income Loss
OperatingIncomeLoss
-437818000
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
50000
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
164000
us-gaap Investment Income Interest
InvestmentIncomeInterest
238000
us-gaap Investment Income Interest
InvestmentIncomeInterest
369000
CY2023Q3 us-gaap Interest Expense
InterestExpense
39599000
CY2022Q4 us-gaap Interest Expense
InterestExpense
28462000
us-gaap Interest Expense
InterestExpense
113542000
us-gaap Interest Expense
InterestExpense
73745000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14143000
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
45140000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27124000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
86523000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101758000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21629000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-107401000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-424671000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-102389000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
24298000
us-gaap Net Income Loss
NetIncomeLoss
-108788000
us-gaap Net Income Loss
NetIncomeLoss
-424255000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189139000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
186113000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
189632000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
185327000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.29
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189139000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
186166000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
189632000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
185327000
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.57
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.29
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-23-061484-index-headers.html Edgar Link pending
0000950170-23-061484-index.html Edgar Link pending
0000950170-23-061484.txt Edgar Link pending
0000950170-23-061484-xbrl.zip Edgar Link pending
avah-20230930.htm Edgar Link pending
avah-20230930.xsd Edgar Link pending
avah-ex31_1.htm Edgar Link pending
avah-ex31_2.htm Edgar Link pending
avah-ex32_1.htm Edgar Link pending
avah-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img23752502_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
avah-20230930_lab.xml Edgar Link unprocessable
avah-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
avah-20230930_cal.xml Edgar Link unprocessable
avah-20230930_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
avah-20230930_def.xml Edgar Link unprocessable